Cueto, Calixto M.
HRN: 14-52-64 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2022
CIPROFLOXACIN 500MG (TAB)
04/29/2022
05/06/2022
PO
500mg
BID
E. Histolytica
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Choice Specific Therapy For E. Histolytica: Metronidazole 500-750mg PO Tid (NAG)
Final appropriateness: No Wrong Choice
Overall appropriateness: No Follow Recommended Antibiotic By NAG